Standard BioTools Hisse

Standard BioTools Kural 40

Standard BioTools (LAB) öğesinin 40 Kuralı değeri 21 Ağu 2026 itibarıyla -160,43 % dir. Önceki yılda, 40 Kuralı -36,43 % idi — 340,38% (daha düşük) bir değişiklik.

Kural 40

-160,43 %

YoY

340,38%

Son güncelleme:

Standard BioTools öğesinin 40 Kuralı değeri 2026 -160,43 % dir. Standard BioTools öğesinin 40 Kuralı değeri 2025 -36,43 % idi. %340,38 daha düşük önceki yıla kıyasla azalmaktadır.
Access this data via the Eulerpool API

Standard BioTools Hisse senedi analizi

Standard BioTools ne yapar? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools, Eulerpool'daki en popüler şirketlerden biridir.

Standard BioTools hisse senedi hakkında sık sorulan sorular

Standard BioTools şirketinin 40 Kuralı değeri 2026 yılında -160,43 %.

Eulerpool'da 40 Kuralı öğesinin Standard BioTools değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

40 Kuralı, şirketin gelir büyüme oranı artı kar marjının 40%'i aşması gerektiğini belirtir. SaaS ve yüksek büyüme gösteren şirketleri değerlendirmek için yaygın olarak kullanılır.

Access this data via the Eulerpool API

Kalite — Standard BioTools

Tüm Kilit Metrikler — Standard BioTools